Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
AIDS and Behavior
|
May 5, 2018
Randomized Trial of a Health Coaching Intervention to Enhance Retention in Care: California Collaborative Treatment Group 594
Katya Corado, Sonia Jain, Sheldon Morris, et al.
Royal Society Open Science
|
March 29, 2022
Source-sink behavioural dynamics limit institutional evolution in a group-structured society
Laurent Hébert-Dufresne, Timothy M Waring, Guillaume St-Onge, et al.
The Journal of Infectious Diseases
|
March 28, 2003
A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team
Judith A Aberg, Paige L Williams, Tun Liu, et al.
The Journal of Infectious Diseases
|
August 22, 2013
Virologic correlates of anti-CMV IgG levels in HIV-1-infected men
Sara Gianella, Sheldon R Morris, Erick Tatro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 15, 2013
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation
Philip M Grant, Douglas Kitch, Grace A McComsey, et al.
Antiviral Therapy
|
September 24, 2016
Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s
Theodoros Kelesidis, Thuy Tien T Tran, Todd T Brown, et al.
The Journal of Infectious Diseases
|
June 30, 2016
Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
Theodoros Kelesidis, Carlee Moser, James H Stein, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 7, 2024
Innovations through crop switching happen on the diverse margins of US agriculture
Matthew M Kling, Christopher T Brittain, Gillian L Galford, et al.
Scientific Reports
|
March 18, 2025
The first-in-Africa ex vivo drug sensitivity testing platform identifies novel drug combinations for South African leukaemia patient cohort
V L Kenmogne, M M Takundwa, E E Nweke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 24, 2015
Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
Theodoros Kelesidis, Thuy Tien T Tran, James H Stein, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
AIDS and Behavior
|
May 5, 2018
Randomized Trial of a Health Coaching Intervention to Enhance Retention in Care: California Collaborative Treatment Group 594
Katya Corado, Sonia Jain, Sheldon Morris, et al.
Royal Society Open Science
|
March 29, 2022
Source-sink behavioural dynamics limit institutional evolution in a group-structured society
Laurent Hébert-Dufresne, Timothy M Waring, Guillaume St-Onge, et al.
The Journal of Infectious Diseases
|
March 28, 2003
A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team
Judith A Aberg, Paige L Williams, Tun Liu, et al.
The Journal of Infectious Diseases
|
August 22, 2013
Virologic correlates of anti-CMV IgG levels in HIV-1-infected men
Sara Gianella, Sheldon R Morris, Erick Tatro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 15, 2013
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation
Philip M Grant, Douglas Kitch, Grace A McComsey, et al.
Antiviral Therapy
|
September 24, 2016
Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s
Theodoros Kelesidis, Thuy Tien T Tran, Todd T Brown, et al.
The Journal of Infectious Diseases
|
June 30, 2016
Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
Theodoros Kelesidis, Carlee Moser, James H Stein, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 7, 2024
Innovations through crop switching happen on the diverse margins of US agriculture
Matthew M Kling, Christopher T Brittain, Gillian L Galford, et al.
Scientific Reports
|
March 18, 2025
The first-in-Africa ex vivo drug sensitivity testing platform identifies novel drug combinations for South African leukaemia patient cohort
V L Kenmogne, M M Takundwa, E E Nweke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 24, 2015
Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
Theodoros Kelesidis, Thuy Tien T Tran, James H Stein, et al.
Page
of 9